Myriad Genetics Inc at UBS Global Healthcare Conference Transcript
So welcome to day 2 of the UBS Global Healthcare Conference. My name is Dan Brennan, I cover life science tools, diagnostics and pharma services. Pleased to be joining us in the stage with the CEO of Myriad Genetics, Mark Capone. Scott Gleason is here in the audience as well. We'll be doing a breakout after this in the Juilliard room.
Before we get started, just want to refer you to the UBS website at www.ubs.com, where you can see all the analyst disclaimers.
I think the format will be, we're going to have Mark, who's going to make some introductory comments. And then after that, we'll go into Q&A, and by all means, don't be shy, I'll look up a few terms during the presentation. If you have any questions, we'll certainly take those. So with that, Mark, welcome and please take it off.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
